Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

RUDN biochemists found out how ROS affect cisplatin resistance in ovarian cancer cells

14.09.2018

Long-term use of anti-cancer drugs treatment may lead to the development of multiple drug resistance reducing the efficiency of chemotherapy. Scientists are aware of several mechanisms for drug resistance development in tumor cells. They are to a great extent associated with the activation of proteins that get medicinal drugs out of cells, as well as with changes in the genes controlling cell survival and programmed cell death (apoptosis). One of the least studied mechanisms of drug resistance development is connected with the influence of reactive oxygen species (ROS) that are formed during cell life and can destroy organic molecules.

RUDN biochemists studied the mechanism of drug resistance development in ovarian cancer cells under treatment with cisplatin. The researchers found out that the process was connected with increased expression (production of proteins coded by DNA molecules) of genes of key antioxidant enzymes (i.e. destroying ROS):


The mechanism of oxidative stress.

Courtesy of Allen Dressen

Mn-superoxide dismutase, catalase, glutathione peroxidase-1, hemoxygenase-1, as well as reduced expression of the enzyme NADPH-oxidase, which is responsible for ROS generation in the cell.

In the normal state there is a balance between the formation and destruction of ROS. Any changes in this balance may cause damage in the internal structure of the cells leading to number of diseases including cancer.

On the other hand, high concentrations of ROS may also lead to the death of cancer cells. This effect is used in cancer therapy, and cisplatin may operate on a similar principle.

In their work the scientists used the real time RT-PCR method and western blotting to evaluate gene expression.

The discovered redox-dependent mechanism of drug resistance development shows how well tumor cells can adapt to negative environmental conditions. The mechanism helps healthy cells survive, but in case of malignant tumors hinders their treatment.

"We found that under treatment of the ovarian cancer cells with cisplatin a new mechanism is triggered, changing the balance between generation and elimination of ROS; it is called as the adaptive antioxidant response.

The studied mechanism of drug resistance development would help create new combined methods for ovarian cancer treatment," said Elena Kalinina, the author of the study, doctor of biological science, and professor of RUDN Institute of Medicine.

Media Contact

Valeriya V. Antonova
antonova_vv@rudn.university

http://eng.rudn.ru/ 

|
Further information:
http://dx.doi.org/10.1002/2211-5463.12453

More articles from Life Sciences:

nachricht Münster University researchers develop new synthesis method for producing fluorinated piperidines
22.01.2019 | Westfälische Wilhelms-Universität Münster

nachricht New blood vessel system discovered in bones
22.01.2019 | Universität Duisburg-Essen

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Energizing the immune system to eat cancer

Abramson Cancer Center study identifies method of priming macrophages to boost anti-tumor response

Immune cells called macrophages are supposed to serve and protect, but cancer has found ways to put them to sleep. Now researchers at the Abramson Cancer...

Im Focus: Ten-year anniversary of the Neumayer Station III

The scientific and political community alike stress the importance of German Antarctic research

Joint Press Release from the BMBF and AWI

The Antarctic is a frigid continent south of the Antarctic Circle, where researchers are the only inhabitants. Despite the hostile conditions, here the Alfred...

Im Focus: Ultra ultrasound to transform new tech

World first experiments on sensor that may revolutionise everything from medical devices to unmanned vehicles

The new sensor - capable of detecting vibrations of living cells - may revolutionise everything from medical devices to unmanned vehicles.

Im Focus: Flying Optical Cats for Quantum Communication

Dead and alive at the same time? Researchers at the Max Planck Institute of Quantum Optics have implemented Erwin Schrödinger’s paradoxical gedanken experiment employing an entangled atom-light state.

In 1935 Erwin Schrödinger formulated a thought experiment designed to capture the paradoxical nature of quantum physics. The crucial element of this gedanken...

Im Focus: Nanocellulose for novel implants: Ears from the 3D-printer

Cellulose obtained from wood has amazing material properties. Empa researchers are now equipping the biodegradable material with additional functionalities to produce implants for cartilage diseases using 3D printing.

It all starts with an ear. Empa researcher Michael Hausmann removes the object shaped like a human ear from the 3D printer and explains:

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Our digital society in 2040

16.01.2019 | Event News

11th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Aachen, 3-4 April 2019

14.01.2019 | Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

 
Latest News

Mechanical engineers develop process to 3D print piezoelectric materials

22.01.2019 | Materials Sciences

Energizing the immune system to eat cancer

22.01.2019 | Health and Medicine

Early Prediction of Alzheimer’s Progression in Blood

22.01.2019 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>